Skip to Main Content
Skip Nav Destination

Issues

Acta Haematologica 2020, Vol. 143, No. 1

Patient Reported Outcomes – Interview

Subject Area: Hematology , Oncology
Acta Haematol (2020) 143 (1): 1–4. https://doi.org/10.1159/000502731

Editorial Comment

Subject Area: Hematology , Oncology
Acta Haematol (2020) 143 (1): 5–6. https://doi.org/10.1159/000501330
Subject Area: Hematology , Oncology
Acta Haematol (2020) 143 (1): 7–8. https://doi.org/10.1159/000501148

Original Paper

Subject Area: Hematology , Oncology
Acta Haematol (2020) 143 (1): 9–18. https://doi.org/10.1159/000500230
Subject Area: Hematology , Oncology
Acta Haematol (2020) 143 (1): 19–25. https://doi.org/10.1159/000500588
Subject Area: Hematology , Oncology
Acta Haematol (2020) 143 (1): 26–32. https://doi.org/10.1159/000500630
Subject Area: Hematology , Oncology
Acta Haematol (2020) 143 (1): 33–39. https://doi.org/10.1159/000500657
Subject Area: Hematology , Oncology
Acta Haematol (2020) 143 (1): 40–50. https://doi.org/10.1159/000500666
Subject Area: Hematology , Oncology
Acta Haematol (2020) 143 (1): 51–59. https://doi.org/10.1159/000500822

Case Report

Subject Area: Hematology , Oncology
Acta Haematol (2020) 143 (1): 60–64. https://doi.org/10.1159/000500797
Subject Area: Hematology , Oncology
Acta Haematol (2020) 143 (1): 65–68. https://doi.org/10.1159/000500975
Subject Area: Hematology , Oncology
Acta Haematol (2020) 143 (1): 69–72. https://doi.org/10.1159/000499861

Brief Communication

Subject Area: Hematology , Oncology
Acta Haematol (2020) 143 (1): 73–77. https://doi.org/10.1159/000500229
Subject Area: Hematology , Oncology
Acta Haematol (2020) 143 (1): 78–88. https://doi.org/10.1159/000500974

Letter to the Editor

Subject Area: Hematology , Oncology
Acta Haematol (2020) 143 (1): 89–90. https://doi.org/10.1159/000500872
Subject Area: Hematology , Oncology
Acta Haematol (2020) 143 (1): 91–92. https://doi.org/10.1159/000500873
Close Modal

or Create an Account

Close Modal
Close Modal